Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

Inclusion Criteria:

• Diabetic patients, regardless of the age of their diabetes, with a grade UT 2 or 3lower limb sore; grade 2: wound penetrating to the tendon or capsule. UT grade 3:wound penetrating to the bone or joint OR hospitalized/ambulatory patients fordiabetic foot sores or amputations, which have not closed or are dehiscent.
• Patients who can tolerate aggressive surgical debridement
• Patients without severe ischemia IPS - 0.6 or pressure of the big toe - 50mmHg
• Longness of the wound: 30 days (does not apply to amputation wounds; patients may beincluded when the wound is less than 30 days old) OR if the amputation level is underthe ankle
• Patients willing and able to give informed consent to participate in the clinicaltrial.
• Male or female over the age of 18
• Patients living at a geographical distance compatible with referral nurse visits
• Negative pregnancy test for women of childbearing age who do not use contraception.
• Patients covered by social security
• Patients who are capable (in the investigator's opinion) and willing to comply withall clinical trial requirements

Exclusion Criteria:

• Patients whose wound surface is not measurable
• Patients with unsealed osteomyelitis
• Patients with fever related to a foot infection (it may be reassessed at a later timewhen the infection is gone)
• Patients with a necrotic wound that will not tolerate aggressive surgical debridement
• Immunosuppressed patients
• Patients with systemic corticosteroids or other treatments that may delay woundhealing
• Pregnant, breast-feeding or planning pregnancy during the clinical trial
• Any other significant disease or disorder that the investigator believes may pose arisk to participants because of their participation in the clinical trial or that mayinfluence the outcome of the clinical trial or the participant's ability toparticipate in the clinical trial.
• Patients with rheumatoid arthritis
• Patients with systemic lupus
• Patients with a known skin allergy to fish
• Patients deprived of liberty by judicial or administrative decision, persons subjectto a legal protection measure